Elucidation of the progression mechanism in renal cell carcinoma via ELOVL5

被引：0
|
作者：
Nitta, Satoshi [1 ]
Kandori, Shuya [1 ]
Sakka, Shotaro [1 ]
Nishiyama, Hiroyuki [1 ]
机构：
[1] Tsukuba Univ, Dept Uro, Fac Med, Tsukuba, Ibaraki, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
YSA-1
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [31] Correction: CircNTNG1 inhibits renal cell carcinoma progression via HOXA5-mediated epigenetic silencing of Slug
    Yanping Liang
    Junjie Cen
    Yong Huang
    Yong Fang
    Yunfei Wang
    Guannan Shu
    Yihui Pan
    Kangbo Huang
    Jiaqi Dong
    Mi Zhou
    Yi Xu
    Junhang Luo
    Min Liu
    Jiaxing Zhang
    Molecular Cancer, 22
  • [32] Traditional and future criteria for progression of renal cell carcinoma
    Pomer, S
    Staehler, G
    UROLOGE A, 1996, 35 (03): : 254 - 262
  • [33] The Role of Extracellular Vesicles In Renal Cell Carcinoma Progression
    Tahyra, Aline Seiko Carvalho
    Colli, Leandro
    van Royer, Martin
    Jenster, Guido
    Almeida, Fausto
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1612 - 1612
  • [34] PREDICTING RENAL CELL CARCINOMA PROGRESSION AFTER SURGERY
    Parker, William
    Lohse, Christine
    Cheville, John
    Zaid, Harras
    Boorjian, Stephen
    Frank, Igor
    Thompson, R. Houston
    Leibovich, Bradley
    JOURNAL OF UROLOGY, 2017, 197 (04): : E954 - E954
  • [35] MCM5 promotes tumour proliferation and correlates with the progression and prognosis of renal cell carcinoma
    Gong, Binbin
    Ma, Ming
    Yang, Xiaorong
    Xie, Wenjie
    Luo, Yanping
    Sun, Ting
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (09) : 1517 - 1526
  • [36] miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5
    Yuan, Chao
    Su, Zhenhong
    Liao, Shengjie
    Li, Duanzhuo
    Zhou, Zhiwen
    Wang, Yawen
    Quan, Mingchun
    Zeng, Lingling
    Lv, Cai
    Shen, Chenyi
    Gong, Weida
    Wu, Jianfeng
    Chen, Xiaogang
    Hu, Wenbing
    Lv, Xu
    Si, Wenxia
    Yu, Xin
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [37] MCM5 promotes tumour proliferation and correlates with the progression and prognosis of renal cell carcinoma
    Binbin Gong
    Ming Ma
    Xiaorong Yang
    Wenjie Xie
    Yanping Luo
    Ting Sun
    International Urology and Nephrology, 2019, 51 : 1517 - 1526
  • [38] miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5
    Chao Yuan
    Zhenhong Su
    Shengjie Liao
    Duanzhuo Li
    Zhiwen Zhou
    Yawen Wang
    Mingchun Quan
    Lingling Zeng
    Cai Lv
    Chenyi Shen
    Weida Gong
    Jianfeng Wu
    Xiaogang Chen
    Wenbing Hu
    Xu Lv
    Wenxia Si
    Xin Yu
    Cancer Cell International, 21
  • [39] Elucidation of the carcinogenic mechanism of translocation renal cell carcinoma by CRISPR/Cas9 genome-wide screening
    Nishizawa, Hidekazu
    Funasaki, Shintaro
    Motoshima, Takanobu
    Yatsuda, Junji
    Baba, Masaya
    Kamba, Tomomi
    CANCER SCIENCE, 2024, 115 : 1278 - 1278
  • [40] Mechanism of action of everolimus in renal cell carcinoma
    Bernard Escudier
    John A. Thompson
    Medical Oncology, 2009, 26 : 32 - 39
12345